Page last updated: 2024-10-26

dup 697 and Inflammation

dup 697 has been researched along with Inflammation in 3 studies

DuP 697: structure given in first source

Inflammation: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beswick, PJ1
Blackaby, AP1
Bountra, C1
Brown, T1
Browning, K1
Campbell, IB1
Corfield, J1
Gleave, RJ1
Guntrip, SB1
Hall, RM1
Hindley, S1
Lambeth, PF1
Lucas, F1
Mathews, N1
Naylor, A1
Player, H1
Price, HS1
Sidebottom, PJ1
Taylor, NL1
Webb, G1
Wiseman, J1
Ozen, G1
Gomez, I1
Daci, A1
Deschildre, C1
Boubaya, L1
Teskin, O1
Uydeş-Doğan, BS1
Jakobsson, PJ1
Longrois, D1
Topal, G1
Norel, X1
Wallace, JL1
Chapman, K1
McKnight, W1

Other Studies

3 other studies available for dup 697 and Inflammation

ArticleYear
Identification and optimisation of a novel series of pyrimidine based cyclooxygenase-2 (COX-2) inhibitors. Utilisation of a biotransformation approach.
    Bioorganic & medicinal chemistry letters, 2009, Aug-01, Volume: 19, Issue:15

    Topics: Biotransformation; Chemistry, Pharmaceutical; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Drug De

2009
Inhibition of microsomal PGE synthase-1 reduces human vascular tone by increasing PGI
    British journal of pharmacology, 2017, Volume: 174, Issue:22

    Topics: Aged; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Epoprostenol; Female; Humans; Inflammation; Male;

2017
Limited anti-inflammatory efficacy of cyclo-oxygenase-2 inhibition in carrageenan-airpouch inflammation.
    British journal of pharmacology, 1999, Volume: 126, Issue:5

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Cyclooxygenase 1; Cyclooxygenase 2; C

1999